KALA Kala Pharmaceuticals, Inc.

NASDAQ
$0.42

Kala Pharmaceuticals, Inc. (KALA) is expected to report earnings on November 18, 2026, before the market open.

Kala Pharmaceuticals Reported Earnings
Wednesday, August 19, 2026 · 12:00 AM ET
Earnings Date
Nov 18
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Kala Pharmaceuticals, Inc.

KALA BIO is a clinical-stage biopharmaceutical company. It focused on the research, development and commercialization of therapies for rare and severe diseases of the eye. The company' s lead product candidate consists KPI-012. KALA BIO, formerly known as Kala Pharmaceuticals Inc., is based in ARLINGTON, Mass.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.